Azitra, Inc.

AMEX:AZTR

Biotechnology

Healthcare
$1.53 +113.99%

+$0.82 today

Market cap
$92.72M
Beta
-1.04
P/E (TTM)
-1.2
EPS (TTM)
-$0.64
52W Low $0.05High $2.13

Volume 146.25M

Average 11.12M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$11.22M

FY 2025 · Annual

Investing Cash Flow

-$182,909.00

FY 2025 · Annual

Financing Cash Flow

$8.92M

FY 2025 · Annual

-33.0% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(8.94M)(10.68M)(11.28M)(8.97M)(10.96M)
Depreciation & Amortization84.77K405.98K425.55K448.24K453.14K
Deferred Income Tax00000
Stock-Based Compensation306.06K184.47K151.51K245.05K62.74K
Change in Working Capital646.35K310.76K(753.43K)(441.72K)(797.23K)
Accounts Receivables194.17K66.67K42.73K133.15K(39.4K)
Inventory00000
Accounts Payables282.98K420.75K(68.68K)(140.54K)0
Other Working Capital169.2K(176.66K)(727.48K)(434.33K)(757.83K)
Other Non-Cash Items(164.86K)1.43M4.1M(1.47M)12.58K
Operating Cash Flow(8.07M)(8.35M)(7.36M)(10.18M)(11.22M)
Capital Expenditures(652.28K)(341.01K)(318.26K)(379.25K)(186.06K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(206.14K)(303.66K)(291.72K)(370.68K)(158.7K)
Investing Cash Flow(652.28K)(336.76K)(318.26K)(379.25K)(182.91K)
Debt Repayment984.39K4.35M(7.39K)(14.6K)(16.06K)
Common Stock Issued005.99M13.35M9.03M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities8.48K(215.38K)0(18.38K)(96.86K)
Financing Cash Flow992.86K4.13M5.98M13.32M8.92M
Effect of Forex Changes00000
Net Change in Cash(7.73M)(4.55M)(1.7M)2.76M(2.49M)
Free Cash Flow(8.72M)(8.69M)(7.68M)(10.56M)(11.41M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$11.0M
+ D&A$453.1K
+ Stock-Based Comp$62.7K
+ Deferred Tax$0
- Working Capital-$797.2K
+ Other Non-Cash$12.6K
= Operating Cash Flow-$11.2M
- Capex-$186.1K
= Free Cash Flow-$11.4M

Analysis

FY2025 free cash flow is -$11.4M. FCF conversion is 104.2% of net income. Operating cash flow was -$11.2M, with capex of -$186.1K. The largest bridge item is Working Capital at -$797.2K.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 26, 2026
8-KCurrent reportOct 22, 2026
8-KCurrent reportOct 1, 2026
8-KCurrent reportSep 28, 2026
424B5424B5 filingSep 28, 2026

Does AZTR generate free cash flow?

Azitra, Inc. (AZTR) generated -$11.41M of free cash flow in fiscal 2025.

How much operating cash flow does AZTR produce?

Operating cash flow was -$11.22M, before capital expenditures of $186,062.00.